These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 10671199

  • 21. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
    Matsumoto K, Watanabe N, Akikusa B, Kurasawa K, Matsumura R, Saito Y, Iwamoto I, Saito T.
    Arthritis Rheum; 2003 Feb; 48(2):486-94. PubMed ID: 12571859
    [Abstract] [Full Text] [Related]

  • 22. T helper cell subsets in the pathogenesis of systemic lupus erythematosus.
    Reininger L, Santiago ML, Takahashi S, Fossati L, Izui S.
    Ann Med Interne (Paris); 1996 Feb; 147(7):467-71. PubMed ID: 9092356
    [Abstract] [Full Text] [Related]

  • 23. Soy isoflavones supplementation alleviates disease severity in autoimmune-prone MRL-lpr/lpr mice.
    Hong Y, Wang T, Huang C, Cheng W, Lin B.
    Lupus; 2008 Sep; 17(9):814-21. PubMed ID: 18755863
    [Abstract] [Full Text] [Related]

  • 24. MRL mice produce anti-Su autoantibody, a specificity associated with systemic lupus erythematosus.
    Treadwell EL, Cohen P, Williams D, O'Brien K, Volkman A, Eisenberg R.
    J Immunol; 1993 Jan 15; 150(2):695-9. PubMed ID: 8419494
    [Abstract] [Full Text] [Related]

  • 25. Host modifier genes affect mouse autoimmunity induced by the lpr gene.
    Wang Y, Nose M, Kamoto T, Nishimura M, Hiai H.
    Am J Pathol; 1997 Dec 15; 151(6):1791-8. PubMed ID: 9403730
    [Abstract] [Full Text] [Related]

  • 26. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.
    J Immunol; 2011 Sep 15; 187(6):3413-21. PubMed ID: 21849682
    [Abstract] [Full Text] [Related]

  • 27. Functional alterations of macrophages in autoimmune MRL-lpr/lpr mice.
    Dang-Vu AP, Pisetsky DS, Weinberg JB.
    J Immunol; 1987 Mar 15; 138(6):1757-61. PubMed ID: 3102599
    [Abstract] [Full Text] [Related]

  • 28. Genomic view of IFN-alpha response in pre-autoimmune NZB/W and MRL/lpr mice.
    Lu Q, Shen N, Li XM, Chen SL.
    Genes Immun; 2007 Oct 15; 8(7):590-603. PubMed ID: 17728792
    [Abstract] [Full Text] [Related]

  • 29. Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C-reactive protein.
    Rodriguez W, Mold C, Marnell LL, Hutt J, Silverman GJ, Tran D, Du Clos TW.
    Arthritis Rheum; 2006 Jan 15; 54(1):325-35. PubMed ID: 16385552
    [Abstract] [Full Text] [Related]

  • 30. Treatment with testosterone or estradiol in melatonin treated females and males MRL/MpJ-Faslpr mice induces negative effects in developing systemic lupus erythematosus.
    Jimenez-Caliani AJ, Jimenez-Jorge S, Molinero P, Rubio A, Guerrero JM, Osuna C.
    J Pineal Res; 2008 Sep 15; 45(2):204-11. PubMed ID: 18507713
    [Abstract] [Full Text] [Related]

  • 31. Knocking out of CD38 accelerates development of a lupus-like disease in lpr mice.
    Viegas MS, Silva T, Monteiro MM, do Carmo A, Martins TC.
    Rheumatology (Oxford); 2011 Sep 15; 50(9):1569-77. PubMed ID: 21586522
    [Abstract] [Full Text] [Related]

  • 32. IFN-gamma limits macrophage expansion in MRL-Fas(lpr) autoimmune interstitial nephritis: a negative regulatory pathway.
    Schwarting A, Moore K, Wada T, Tesch G, Yoon HJ, Kelley VR.
    J Immunol; 1998 Apr 15; 160(8):4074-81. PubMed ID: 9558118
    [Abstract] [Full Text] [Related]

  • 33. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.
    Miyazaki T, Ono M, Qu WM, Zhang MC, Mori S, Nakatsuru S, Nakamura Y, Sawasaki T, Endo Y, Nose M.
    Eur J Immunol; 2005 May 15; 35(5):1510-20. PubMed ID: 15832294
    [Abstract] [Full Text] [Related]

  • 34. B cell genotype determines the fine specificity of autoantibody in lpr mice.
    Kakkanaiah VN, Sobel ES, MacDonald GC, Cheek RL, Cohen PL, Eisenberg RA.
    J Immunol; 1997 Jul 15; 159(2):1027-35. PubMed ID: 9218626
    [Abstract] [Full Text] [Related]

  • 35. Systemic autoimmune disease induced by dendritic cells that have captured necrotic but not apoptotic cells in susceptible mouse strains.
    Ma L, Chan KW, Trendell-Smith NJ, Wu A, Tian L, Lam AC, Chan AK, Lo CK, Chik S, Ko KH, To CK, Kam SK, Li XS, Yang CH, Leung SY, Ng MH, Stott DI, MacPherson GG, Huang FP.
    Eur J Immunol; 2005 Nov 15; 35(11):3364-75. PubMed ID: 16224814
    [Abstract] [Full Text] [Related]

  • 36. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
    Yajima K, Nakamura A, Sugahara A, Takai T.
    Eur J Immunol; 2003 Apr 15; 33(4):1020-9. PubMed ID: 12672068
    [Abstract] [Full Text] [Related]

  • 37. Behavioral effects of infection with interferon-gamma adenovector.
    Kwant A, Sakic B.
    Behav Brain Res; 2004 May 05; 151(1-2):73-82. PubMed ID: 15084423
    [Abstract] [Full Text] [Related]

  • 38. Interferon-beta: a therapeutic for autoimmune lupus in MRL-Faslpr mice.
    Schwarting A, Paul K, Tschirner S, Menke J, Hansen T, Brenner W, Kelley VR, Relle M, Galle PR.
    J Am Soc Nephrol; 2005 Nov 05; 16(11):3264-72. PubMed ID: 16221871
    [Abstract] [Full Text] [Related]

  • 39. IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Muraoka M, Hasegawa H, Kohno M, Inoue A, Miyazaki T, Terada M, Nose M, Yasukawa M.
    Arthritis Rheum; 2006 Nov 05; 54(11):3591-600. PubMed ID: 17075801
    [Abstract] [Full Text] [Related]

  • 40. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P, Langnickel D, Riemekasten G.
    Scand J Rheumatol; 2006 Nov 05; 35(3):209-16. PubMed ID: 16766368
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.